Thiazolidinediones are associated with a reduced risk of COPD exacerbations

BACKGROUND: Thiazolidinediones (TZDs) are oral antihyperglycemic medications that are selective agonists to peroxisome proliferator-activated receptor gamma and have been shown to have potent anti-inflammatory effects in the lung. OBJECTIVE: The purpose of this study was to assess whether exposure t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Chron Obstruct Pulmon Dis
Auteurs principaux: Rinne, Seppo T, Liu, Chuan-Fen, Feemster, Laura C, Collins, Bridget F, Bryson, Christopher L, O’Riordan, Thomas G, Au, David H
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2015
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4536761/
https://ncbi.nlm.nih.gov/pubmed/26300638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S82643
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires